AmerisourceBergen (AB), a global healthcare solutions leader, announced today that it has reached an agreement to extend its strategic relationship with Cancer Specialists of North Florida (CSNF), an oncology provider with the largest cancer practice in Jacksonville, specializing in medical oncology, radiation oncology, hematology and diagnostic imaging. The 5-year agreement enables AmerisourceBergen’s continued support of technology, analytics and specialty drug distribution services f

Accuray Incorporated announced today that data from a phase III, randomized controlled trial, TomoBreast, indicate post-surgery hypofractionated radiotherapy delivered with the TomoTherapy® System is superior to conventional radiotherapy in preserving long-term heart and lung functioning in women with early breast cancer. An analysis of patient reported outcomes showed 10-year survival free of heart and lung deterioration was 84.5% with TomoTherapy delivered radiotherapy - a significant i

Medovate, a UK based medical device development company, has announced that it has entered into an agreement with Mercury Medical for exclusive distribution of the FDA-cleared device SAFIRA® (SAFer Injection for Regional Anesthesia) across the whole of the United States (US).   The agreement also includes the newly launched SAFIRA® Palm Operator which has been launched in the US market to offer anesthesiologists more versatility and choice when using the SAFIRA® reg

Imagia Cybernetics, an AI-healthcare company that accelerates oncology solutions generated from real world data, today announced its merger with Canexia Health. Canexia is an oncology innovator that streamlines complex cancer genomic information which allows oncologists to identify optimal treatment selection and patient monitoring. The merger includes C$20 million funding with participation from: BDC Capital’s Women in Technology Venture Fund, Desjardins Capital, and PacBridge Capital.

Labcorp, a leading global life sciences company, today announced that it has entered into agreements to create a comprehensive strategic relationship with Ascension, one of the nation’s leading Catholic and non-profit health systems. Through the expansive strategic collaboration, Labcorp will manage Ascension’s hospital-based laboratories in 10 states and purchase select assets of the health system’s outreach laboratory business. This long-term relationship will expand Labco

U.S. Orthopaedic Partners ("USOP"), the rapidly-expanding network for private orthopaedic practices in the Southeastern United States and creator of the unique orthopedic care platform addressing the continuum of musculoskeletal care, finalized today a new partnership agreement with Southern Orthopaedic Surgeons LLC  in Montgomery, Ala.   With four facilities, led by 10 world-class orthopaedic physicians offering surgical, non-surgical, and injury prevention care

Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced the first worldwide commercial procedures using the RheOx® Bronchial Rheoplasty system for the treatment of the symptoms of chronic bronchitis. The first Bronchial Rheoplasty cases were performed by Professor Stefano Gasparini, Polytechnic University of Marche hospital, and Dr. Lina Zuccatosta, Director Pulmonary Diseases Unit, University Hospital Ancona in Ancona, Italy. Dr. Michela

Invacare Corporation announced the introduction of its next generation of power assist devices – the e-fix eco. The Alber™ e-fix eco Power Assist transforms a manual wheelchair into a portable power chair via a joystick, battery and in-wheel motors. Equipped with a new modern design for the wheel hub, color display, battery, and battery bag, the e-fix eco represents a significant upgrade from the previous generation. In addition, the eco features a clutch, multiple joyst

Labcorp, a leading global life sciences company, today announced the opening of a new diagnostics laboratory in South Bend, Indiana, allowing the company to enhance service levels and offerings to patients and physicians in South Bend and throughout the region. The approximately 25,000-square-foot facility features expanded capabilities and new equipment for performing high-quality and efficient testing—creating more robust lab offerings for the community. The laboratory, whic

Artemis DNA, Inc., a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic testing that enables "personalized" medicine through early disease detection,  proudly announced that they have received a second accreditation from the College of American Pathologists (CAP) for its Irvine, California facility, the first accreditation was for its Houston, Texas facility. The CAP is a